Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Persson

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
The dosimetric effect of residual breath-hold motion in pencil beam scanned proton therapy - An experimental studyJenny Gorgisyan, Antony J Lomax, Per Munck Af Rosenschold, et al.
The British Journal of Radiology|August 25, 2012
Interobserver delineation variation in lung tumour stereotactic body radiotherapyG F Persson, D E Nygaard, C Hollensen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 31, 2023
Does coronary artery calcium score have an impact on overall survival for locally advanced non-small cell lung cancer treated with definitive radiotherapyAgon Olloni, Carsten Brink, Ebbe L Lorenzen, et al.
Plos One|April 29, 2020
Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients - initial observationsLotte Nygård, Lise B Ahlborn, Gitte F Persson, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 22, 2020
Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-studyM Piazza, N M J Hanssen, F Persson, et al.
Diabetes, Obesity & Metabolism|October 30, 2015
Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trialH J L Heerspink, T Ninomiya, F Persson, et al.
Medical Physics|March 3, 2022
Synthetic 4DCT(MRI) lung phantom generation for 4D radiotherapy and image guidance investigationsAlisha Duetschler, Grzegorz Bauman, Oliver Bieri, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 14, 2022
Thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for stereotactic body radiotherapy (SBRT) of central and ultra-central lung tumoursL Hoffmann, G F Persson, L Nygård, et al.
Journal of Pharmacological and Toxicological Methods|March 28, 2006
Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HTM H Bridgland-Taylor, A C Hargreaves, A Easter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2025
Design and pre-trial dose planning quality assurance of the Nordic trial of inhomogeneous dose escalated radiotherapy for patients with limited disease small cell lung cancer: NIELSSara Linde, Ditte S Møller, Mai-Britt Linaa, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
The dosimetric effect of residual breath-hold motion in pencil beam scanned proton therapy - An experimental studyJenny Gorgisyan, Antony J Lomax, Per Munck Af Rosenschold, et al.
The British Journal of Radiology|August 25, 2012
Interobserver delineation variation in lung tumour stereotactic body radiotherapyG F Persson, D E Nygaard, C Hollensen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 31, 2023
Does coronary artery calcium score have an impact on overall survival for locally advanced non-small cell lung cancer treated with definitive radiotherapyAgon Olloni, Carsten Brink, Ebbe L Lorenzen, et al.
Plos One|April 29, 2020
Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients - initial observationsLotte Nygård, Lise B Ahlborn, Gitte F Persson, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 22, 2020
Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-studyM Piazza, N M J Hanssen, F Persson, et al.
Diabetes, Obesity & Metabolism|October 30, 2015
Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trialH J L Heerspink, T Ninomiya, F Persson, et al.
Medical Physics|March 3, 2022
Synthetic 4DCT(MRI) lung phantom generation for 4D radiotherapy and image guidance investigationsAlisha Duetschler, Grzegorz Bauman, Oliver Bieri, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 14, 2022
Thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for stereotactic body radiotherapy (SBRT) of central and ultra-central lung tumoursL Hoffmann, G F Persson, L Nygård, et al.
Journal of Pharmacological and Toxicological Methods|March 28, 2006
Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HTM H Bridgland-Taylor, A C Hargreaves, A Easter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2025
Design and pre-trial dose planning quality assurance of the Nordic trial of inhomogeneous dose escalated radiotherapy for patients with limited disease small cell lung cancer: NIELSSara Linde, Ditte S Møller, Mai-Britt Linaa, et al.
Pageof 7